Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Wayfair
W
$11B
| $291M | 0.14% |
3,866,708
+296,233
| +8% | +$26.8M |
|
152
Emerson Electric
EMR
$82.9B
| $289M | 0.14% |
2,207,707
+1,079,665
| +96% | +$155M |
|
153
Burlington
BURL
$21.7B
| $286M | 0.14% |
880,017
+8,361
| +1% | +$2.56M |
|
154
Procter & Gamble
PG
$342B
| $285M | 0.14% |
1,969,836
-53,252
| -3% | -$8.07M |
|
155
O'Reilly Automotive
ORLY
$71.6B
| $283M | 0.14% |
3,062,102
+850,312
| +38% | +$79.7M |
|
156
Gilead Sciences
GILD
$161B
| $275M | 0.13% |
1,972,639
+110,525
| +6% | +$15.5M |
|
157
Lockheed Martin
LMT
$134B
| $273M | 0.13% |
451,276
+438,732
| +3,498% | +$270M |
|
158
Cimpress
CMPR
$2.38B
| $271M | 0.13% |
3,713,187
+92,764
| +3% | +$6.86M |
|
159
Casey's General Stores
CASY
$32.3B
| $269M | 0.13% |
369,218
-79,681
| -18% | -$51.9M |
|
160
Willis Towers Watson
WTW
$27.4B
| $263M | 0.13% |
903,762
+9,232
| +1% | +$2.83M |
|
161
Illumina
ILMN
$29.3B
| $259M | 0.12% |
2,100,638
+29,094
| +1% | +$3.82M |
|
162
TransUnion
TRU
$14.5B
| $259M | 0.12% |
3,740,326
+293,091
| +9% | +$22.4M |
|
163
Structure Therapeutics
GPCR
$3.56B
| $258M | 0.12% |
5,354,981
+264,833
| +5% | +$18.1M |
|
164
CDW
CDW
$16.9B
| $257M | 0.12% |
2,125,605
-27,066
| -1% | -$3.42M |
|
165
UL Solutions
ULS
$17.7B
| $256M | 0.12% |
2,987,691
-37,129
| -1% | -$2.93M |
|
166
Vistra
VST
$57B
| $254M | 0.12% |
1,691,315
-1,267,425
| -43% | -$205M |
|
167
CVS Health
CVS
$138B
| $254M | 0.12% |
3,536,861
-80,085
| -2% | -$6.17M |
|
168
Sterling Infrastructure
STRL
$21.5B
| $252M | 0.12% |
619,145
+43,259
| +8% | +$16.9M |
|
169
Marvell Technology
MRVL
$178B
| $250M | 0.12% |
2,524,737
-81,727
| -3% | -$6.86M |
|
170
Dyne Therapeutics
DYN
$4.03B
| $247M | 0.12% |
13,647,376
-240,346
| -2% | -$4.14M |
|
171
Medtronic
MDT
$106B
| $246M | 0.12% |
2,835,816
-278,342
| -9% | -$26.7M |
|
172
Chipotle Mexican Grill
CMG
$41.1B
| $246M | 0.12% |
7,760,935
-88,983
| -1% | -$3.29M |
|
|
LGN
173
Legence Corp
LGN
$5.65B
| $245M | 0.12% |
4,341,989
-59,413
| -1% | -$2.99M |
|
174
Xenon Pharmaceuticals
XENE
$6.27B
| $243M | 0.12% |
4,175,982
+91,948
| +2% | +$4.24M |
|
175
IDEAYA Biosciences
IDYA
$3.53B
| $242M | 0.12% |
7,265,253
+78,797
| +1% | +$2.64M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.